Cargando…

Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567262/
https://www.ncbi.nlm.nih.gov/pubmed/37829649
http://dx.doi.org/10.1155/2023/9780837
_version_ 1785119087381184512
author and Alternative Medicine, Evidence-Based Complementary
author_facet and Alternative Medicine, Evidence-Based Complementary
author_sort and Alternative Medicine, Evidence-Based Complementary
collection PubMed
description
format Online
Article
Text
id pubmed-10567262
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105672622023-10-12 Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-10-04 /pmc/articles/PMC10567262/ /pubmed/37829649 http://dx.doi.org/10.1155/2023/9780837 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Alternative Medicine, Evidence-Based Complementary
Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
title Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
title_full Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
title_fullStr Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
title_full_unstemmed Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
title_short Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
title_sort retracted: a novel biomarker, fkbp10, for poor prognosis prediction in patients with clear cell renal cell carcinoma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567262/
https://www.ncbi.nlm.nih.gov/pubmed/37829649
http://dx.doi.org/10.1155/2023/9780837
work_keys_str_mv AT andalternativemedicineevidencebasedcomplementary retractedanovelbiomarkerfkbp10forpoorprognosispredictioninpatientswithclearcellrenalcellcarcinoma